Literature DB >> 10673820

Olanzapine in Tourette's disorder.

Z Bengi Semerci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10673820     DOI： 10.1097/00004583-200002000-00008

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  8 in total

Review 1.  The safety of olanzapine in young children: a systematic review and meta-analysis.

Authors:  Jacqueline Flank; Lillian Sung; Christopher C Dvorak; Wendy Spettigue; L Lee Dupuis
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

Review 2.  Tourette syndrome: clinical characteristics and current management strategies.

Authors:  E H Kossoff; H S Singer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Tolerability profile of atypical antipsychotics in children and adolescents.

Authors:  K A Stigler; M N Potenza; C J McDougle
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 6.  The treatment of tics.

Authors:  H S Singer
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 6.030

7.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

8.  Update on the role of antipsychotics in the treatment of Tourette syndrome.

Authors:  Daniel Huys; Katja Hardenacke; Pia Poppe; Christina Bartsch; Burak Baskin; Jens Kuhn
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-12       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.